These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

42 related items for PubMed ID: 8344646

  • 1. Pyridostigmine effects on TSH response to TRH in adult and children obese subjects.
    Mancini A, Fiumara C, Conte G, Sammartano L, Fabrizi ML, Iacona T, Valle D, De Marinis L.
    Horm Metab Res; 1993 Jun; 25(6):309-11. PubMed ID: 8344646
    [Abstract] [Full Text] [Related]

  • 2. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
    Coiro V, Volpi R, Capretti L, Caffarri G, Colla R, Chiodera P.
    J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH.
    Coiro V, Volpi R, Cataldo S, Capretti L, Caffarri G, Pilla S, Chiodera P.
    J Investig Med; 2000 Mar; 48(2):133-6. PubMed ID: 10736973
    [Abstract] [Full Text] [Related]

  • 4. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics.
    Coiro V, Vescovi PP.
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging.
    Giusti M, Giovale M, Sessarego P, Carraro A, Pompei A, Giordano G.
    Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Different effects of pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression and subclinical thyrotoxicosis.
    Coiro V, Volpi R, Marchesi C, DeFerri A, Capretti L, Caffarri G, Colla R, Chiodera P.
    Metabolism; 1998 Jan; 47(1):50-3. PubMed ID: 9440477
    [Abstract] [Full Text] [Related]

  • 9. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP, Jacobs LS, Hoffman W, Daughaday WH, Blizzard RM.
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [Abstract] [Full Text] [Related]

  • 10. Pyridostigmine and metoclopramide do not restore the TSH response to TRH inhibited by L-thyroxine treatment in children with goiter.
    Radetti G, Bernasconi S, Bozzola M, Volta C, Tonini G, Gentili L, Rigon F.
    J Endocrinol Invest; 2000 Dec; 23(11):744-7. PubMed ID: 11194708
    [Abstract] [Full Text] [Related]

  • 11. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP, Owings J, Hayford JT, Blizzard RM.
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [Abstract] [Full Text] [Related]

  • 12. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F.
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.
    Harris AR, Christianson D, Smith MS, Fang SL, Braverman LE, Vagenakis AG.
    J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840
    [Abstract] [Full Text] [Related]

  • 15. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Conte G, Sammartano L, Fabrizi ML, Valle D.
    Exp Clin Endocrinol Diabetes; 1996 Feb; 104(1):67-71. PubMed ID: 8750573
    [Abstract] [Full Text] [Related]

  • 16. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [Abstract] [Full Text] [Related]

  • 17. Combined pyridostigmine-thyrotrophin-releasing hormone test for the evaluation of hypothalamic somatostatinergic activity in healthy normal men.
    Yang I, Woo J, Kim S, Kim J, Kim Y, Choi Y.
    Eur J Endocrinol; 1995 Oct; 133(4):457-62. PubMed ID: 7581970
    [Abstract] [Full Text] [Related]

  • 18. The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly.
    Hanew K, Utsumi A, Sugawara A, Shimizu Y, Ikeda H, Abe K.
    J Endocrinol Invest; 1994 May; 17(5):313-21. PubMed ID: 7915736
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of pretreatment with pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in patients with Cushing's disease.
    Giustina A, Bossoni S, Buffoli MG, Ferrari C, Pozzi A, Scalvini T, Schettino M.
    Horm Metab Res; 1992 May; 24(5):248-50. PubMed ID: 1398468
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.